ArticleBMC infectious diseases2025
Characterization and diversity of methicillin-resistant Staphylococcus aureus in two hospitals in Gabon.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Nasal colonization, risk factors, and antibiotic resistance of methicillin-resistantFrontiers in microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMethicillin-resistant Staphylococcus aureus (MRSA) poses a significant global health threat, particularly within the ESKAPE pathogens. Surveillance in Sub-Saharan Africa, including Gabon, remains limited despite reported high rates of Panton-Valentine leukocidin (PVL)-positive S. aureus and emerging MRSA clones.
methodsA prospective longitudinal study was conducted at two hospitals in Northern (CHRO) and Southeastern (CHUAB) Gabon. Nasal swabs were collected from 200 patients (100 per hospital) upon admission (D0) and serially over 6 days. Environmental swabs were also taken. S. aureus isolates were identified, and MRSA confirmed of mecA gene detection. Characterization included spa typing, SCCmec typing, the lukS/F-PV gene detection, antimicrobial susceptibility testing (EUCAST), and detection of the dfrG trimethoprim resistance gene. Clonal complexes (CC) were inferred.
resultsMRSA nasal carriage prevalence was worrying high (60% of S. aureus carriers overall), reaching 70% at CHRO. PVL genes (65% of MRSA isolates) were occurring equally in community-associated (CA, 63%) and hospital-associated (HA, 69%) MRSA. CC5-ST5 (primarily spa t311/t003, SCCmec IV) dominated CA-MRSA (37%) and environmental isolates. Other virulent CA-MRSA clones (CC8, CC80, CC152) were detected. A high proportion of strains were non-typeable by MLST-CC (72% patient, 78% environmental) and SCCmec (37% CA-MRSA), suggesting novel lineages. MRSA exhibited resistance: tetracycline (59%), trimethoprim-sulfamethoxazole (SXT, 31%; 94% mediated by dfrG), ciprofloxacin (26%). No significant resistance difference existed between CA- and HA-MRSA. Environmental contamination was extensive (72% of environmental S. aureus were MRSA), with overlapping clones (CC5-ST5, CC121, spa t653) implicating cross-transmission. Cumulative incidence indicated a 17.1% risk of acquiring new colonization within 6 days of admission. MRSA burden was significantly higher at the northern border hospital (CHRO).
conclusionThis study reveals a critical public health threat in Gabonese hospitals, characterized by virulent (high PVL), resistant MRSA clones circulating actively between patients and the environment. The dominance of CC5-ST5 in CA-MRSA, high rates of non-typeable strains highlight unique epidemiological features.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.